|
Market Closed -
Nasdaq
16:00:00 2026-09-25 EDT
|
5-day change | 1st Jan Change | ||
| 1.360 USD | -4.90% |
|
-19.53% | -67.31% |
| 09-14 | Dogwood Therapeutics Completes Enrollment In Halneuron Phase 2b Chemotherapy Induced Neuropathic Pain Trial | CI |
| 09-01 | Dogwood Therapeutics, Inc. - Special Call |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| DWTX | Delayed | |
CBOE
| DWTX | Real-time |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Neutral | Bearish |
| Resistance | 1.94 | 2.68 | 2.65 |
| Spread/Res. | -29.90% | -49.25% | -48.68% |
| Spread/Supp. | +1.49% | +1.49% | +86.74% |
| Support | 1.34 | 1.34 | 0.7283 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- DWTX Stock
- Charts Dogwood Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
